FDA Provides EUA for PerkinElmer’s Coronavirus Nucleic Acid Detection Kit
The kit is a real-time RT-PCR test using samples from oropharyngeal and nasopharyngeal swabs.
Read MorePosted by | Apr 1, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases, Molecular Diagnostics |
The kit is a real-time RT-PCR test using samples from oropharyngeal and nasopharyngeal swabs.
Read MorePosted by Steve Halasey | Mar 31, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
Abbott’s new test is the fastest available molecular point-of-care test for the diagnosis of covid-19, delivering positive results in as little as 5 minutes and negative results in 13 minutes.
Read MorePosted by Steve Halasey | Mar 31, 2020 | Compliance, Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases, Lab Management |
The waiver will provide temporary relief from federal regulations requiring pathologists to render primary diagnoses onsite at healthcare facilities.
Read MorePosted by | Mar 31, 2020 | Emerging & Zoonotic Diseases, Hematology & Serology, Infectious Diseases, Serology Instrumentation |
The Diazyme DZ-Lite SARS-CoV-2 IgG and SARS-CoV-2 IgM CLIA test kits are run on the fully automated Diazyme DZ-Lite 3000 Plus chemiluminescence analyzer.
Read MorePosted by | Mar 31, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
Mount Sinai researchers are working to design and validate a clinical pathology laboratory solution for testing, treatment, and monitoring of covid-19.
Read More